DRY AGE-RELATED MACULAR DEGENERATION
Clinical trials for DRY AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new DRY AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for DRY AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a daily injection save your sight? new trial for dry AMD
Disease control OngoingThis phase 3 trial tests whether a daily injection of elamipretide can slow vision loss in people with dry age-related macular degeneration (AMD). About 313 adults aged 55 and older with early dry AMD will receive either the drug or a placebo for 96 weeks. The main goal is to see…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: PHASE3 • Sponsor: Stealth BioTherapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Bionic eye implant aims to restore sight in dry AMD patients
Disease control OngoingThis early feasibility trial tests a new retinal implant called PRIMA in 5 people with advanced dry age-related macular degeneration who have lost central vision. The device is surgically placed in the eye to stimulate remaining retinal cells. Researchers are checking if it is sa…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: Science Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC